Eli Lilly and Company Stock News

We're highlighting the 25 best-performing stocks in the S&P 1500 on a total return basis over the last five years. At the top of the list, above even Nvidia, is Alpha Metallurgical, which mines and produces coal for steel production and power generation. NVDA ranks second, turning $1,000 five years ago into more than $25,000 today, followed by energy drink maker Celsius, MARA Holdings, and Game...

For income investors, closed-end funds remain an attractive investment class that covers various asset classes and promises high distributions and reasonable total returns. Closed-end funds, or CEFs, are generally characterized by higher volatility and deeper drawdowns than the broader market. For these reasons, they are not suited for everyone. In this monthly series, we highlight five CEFs wi...

LLY's recent sell-off has been unwarranted indeed, since the lowered FY2024 guidance is attributed to the complexities of inventory management and non-cash/ one-time IPR&D charges. Even so, the pullback has been a gift for opportunistic investors, with the stock now trading nearer to our recommended buy zones. If anything, LLY is even cheaper at FWD PEG non-GAAP ratio of 0.85x, well below histo...

After flying high during the first half of the year, pharmaceutical giant Eli Lilly (LLY -0.26%) has lost some momentum; the company's shares are down by 11% since June 1. However, the healthcare leader still has plenty of fans on Wall Street, including Israel Englander, the billionaire owner of Millennium Management, a hedge fund.

We present a highly diversified yet simple portfolio of 10 positions, with 9 funds and one individual MLP stock. The portfolio has been designed for retirees and investors planning for retirement, with a 6% current income yield and potentially 6% plus dividend growth. The portfolio presented uses a hands-off approach, and it is diversified among many asset classes as well as different sectors o...

2 Incredible Growth Stocks to Buy With $1,000 Right Now

Investing in Pharma Stocks? Check These 3 Things First

Robert F. Kennedy Jr.'s potential appointment to HHS has spooked Eli Lilly stock and stocks tied to popular weight-loss drugs. The post Weight-Loss Drugs Don't Seem To Impress RFK Jr. Should Eli Lilly, Novo Nordisk Investors Worry?